1. Home
  2. TFPM vs ADMA Comparison

TFPM vs ADMA Comparison

Compare TFPM & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFPM
  • ADMA
  • Stock Information
  • Founded
  • TFPM 2016
  • ADMA 2004
  • Country
  • TFPM Canada
  • ADMA United States
  • Employees
  • TFPM N/A
  • ADMA N/A
  • Industry
  • TFPM Precious Metals
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TFPM Industrials
  • ADMA Health Care
  • Exchange
  • TFPM Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • TFPM 5.7B
  • ADMA 5.1B
  • IPO Year
  • TFPM N/A
  • ADMA N/A
  • Fundamental
  • Price
  • TFPM $28.13
  • ADMA $15.69
  • Analyst Decision
  • TFPM Strong Buy
  • ADMA Strong Buy
  • Analyst Count
  • TFPM 3
  • ADMA 3
  • Target Price
  • TFPM $23.67
  • ADMA $27.67
  • AVG Volume (30 Days)
  • TFPM 617.1K
  • ADMA 2.9M
  • Earning Date
  • TFPM 11-04-2025
  • ADMA 11-06-2025
  • Dividend Yield
  • TFPM 0.79%
  • ADMA N/A
  • EPS Growth
  • TFPM N/A
  • ADMA 469.09
  • EPS
  • TFPM 0.86
  • ADMA 0.85
  • Revenue
  • TFPM $324,214,000.00
  • ADMA $474,174,000.00
  • Revenue This Year
  • TFPM $33.78
  • ADMA $21.08
  • Revenue Next Year
  • TFPM $3.53
  • ADMA $25.98
  • P/E Ratio
  • TFPM $32.92
  • ADMA $18.53
  • Revenue Growth
  • TFPM 45.86
  • ADMA 43.58
  • 52 Week Low
  • TFPM $14.51
  • ADMA $13.50
  • 52 Week High
  • TFPM $29.30
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • TFPM 59.75
  • ADMA 36.86
  • Support Level
  • TFPM $27.89
  • ADMA $15.14
  • Resistance Level
  • TFPM $29.30
  • ADMA $17.17
  • Average True Range (ATR)
  • TFPM 0.81
  • ADMA 0.55
  • MACD
  • TFPM 0.01
  • ADMA -0.12
  • Stochastic Oscillator
  • TFPM 64.64
  • ADMA 22.59

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: